The FDA has selected a facility for a PreCheck Pilot Program involving Kyowa Kirin.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has selected a facility for a PreCheck Pilot Program involving Kyowa Kirin.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Kyowa Kirin
pharmaceutical company
Nothing else this week.
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approval enables commercial availability for a product associated with Indianapolis.
- An AI software company based in Baltimore is seeking FDA clearance and planning a clinic pilot in New Orleans.
- A company is seeking definitive data for a pre-NDA meeting with the FDA in Raleigh.
- FDA approval preceded a device showcase event held in Las Vegas on October 13, 2026.